Nasdaq

Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform

- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes - Abbott and eMed™ expect to deliver and administer 30 ...
Nasdaq

Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use

ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...
The New York Times

A Rapid Test Offers Hope for Community Screening

In a small study in San Francisco, Abbott’s BinaxNOW identified infectious people nearly as accurately as a P.C.R. test. By Apoorva Mandavilli A $5 rapid test for the coronavirus may be nearly as ...